If you've landed here searching for the best supplements for Raynaud's, you're probably either newly diagnosed with fingers that go white in the cold and want to do everything you can short of medication, or you're already on a calcium channel blocker and wondering whether anything from the supplement aisle adds another layer.
Before you decide
What Raynaud's Phenomenon Actually Is
Raynaud's is an exaggerated vasoconstrictive response of the small arteries and arterioles in the fingers and toes (and sometimes nose, ears, and nipples) to cold or emotional stress, producing the classic white-blue-red color sequence. It splits into two clinically distinct entities and they behave differently.
Primary Raynaud's (Raynaud's disease) is idiopathic, typically starts in the teens or twenties, is more common in women, has no underlying connective tissue disease, has normal nailfold capillaries, has negative or very low-titer ANA, and rarely causes tissue damage. The risk profile is benign and supplements are reasonable adjuncts.
Secondary Raynaud's (Raynaud's phenomenon) is associated with systemic sclerosis (scleroderma), lupus, mixed connective tissue disease, dermatomyositis, Sjögren's, vibration injury, certain medications (beta blockers, stimulants, some chemotherapy agents), and rarely cryoglobulinemia. It tends to start later (after age 30), affects men more than primary does, and can progress to digital ulcers and gangrene. Standard of care here involves rheumatology management, not a supplement-first approach.
Conventional first-line treatment for symptomatic Raynaud's that's interfering with daily life is a dihydropyridine calcium channel blocker (most commonly nifedipine extended-release or amlodipine), per the 2017 ACR/EULAR systemic sclerosis treatment recommendations for secondary Raynaud's and similar guidance from the Raynaud's Association for primary disease. Lifestyle measures, including cold avoidance with layered gloves, hand warmers, smoking cessation, and biofeedback, come before and continue alongside any pharmacotherapy. Supplements are a layer on top of that, not a substitute.
The Supplements With the Strongest Evidence
Ginkgo biloba (standardized EGb 761 extract)
Why it helps. Ginkgo's standardized extract has effects on platelet-activating factor, endothelial nitric oxide, and small-vessel blood flow. The mechanism is plausible and supported by Doppler studies showing modest improvements in digital perfusion.
What the trials show. In a small but methodologically clean placebo-controlled RCT (Muir et al., 2002, n=22, 10 weeks), patients with primary Raynaud's taking EGb 761 360 mg/day reported a 56% reduction in attack frequency vs about 27% with placebo. A 2008 head-to-head trial against nifedipine (Choi et al., n=41) found ginkgo reduced attack frequency by roughly 31% and nifedipine by about 51%, putting ginkgo below the standard pharmacologic option but still above no treatment. Evidence in secondary (scleroderma-associated) Raynaud's is thinner and less consistent.
Dose used in trials. 120 mg three times daily (360 mg total) of the EGb 761 standardized extract, taken with food. Some smaller protocols used 120 mg twice daily.
Form to look for. "EGb 761" or "standardized to 24% flavone glycosides and 6% terpene lactones" on the label. Generic "ginkgo leaf powder" without standardization will not match the trial product.
Skip if you're on warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, prasugrel, ticagrelor, or daily aspirin without explicit clearance from your prescriber. The Drugs.com ginkgo–warfarin interaction monograph flags an increased bleeding risk, with case reports of spontaneous intracerebral and ocular hemorrhage. This interaction is not theoretical. Also skip in the 2 weeks before any planned surgery.
Omega-3 EPA/DHA (fish oil)
Why it helps. Long-chain omega-3s shift eicosanoid balance toward less vasoconstrictive prostaglandins and modestly improve endothelial function. The direct Raynaud's signal is weaker than the cardiovascular signal but the mechanism overlaps.
What the trials show. A small RCT (DiGiacomo et al., 1989, n=32) found that 12 weeks of fish oil delayed the onset of Raynaud's attacks during cold challenge in primary but not in secondary Raynaud's. Effect size was modest. The broader NIH ODS omega-3 fact sheet summarizes the cardiovascular and endothelial evidence base, which is more relevant if you have scleroderma-associated Raynaud's and elevated baseline vascular risk.
Dose used in trials. 1 to 2 grams of combined EPA + DHA daily, with food. The fish-oil Raynaud's trial used a higher dose (approximately 3.96 g EPA + 2.64 g DHA in one arm), but routine adjunctive dosing in the 1–2 g range is what most current cardiovascular adjunct protocols target.
Form to look for. EPA-dominant or balanced EPA/DHA formulations, third-party tested for oxidation (IFOS, USP, or ConsumerLab approved). Triglyceride or re-esterified triglyceride forms are reasonable defaults.
Skip if you're on therapeutic-dose anticoagulation without checking with the prescriber, or if you have a documented fish allergy. The bleeding effect at 1–2 g/day is small but real in combination with warfarin.
Magnesium (glycinate, citrate, or malate)
Why it helps. Magnesium acts as a natural calcium channel modulator and is a mild vasodilator. The framing for Raynaud's is mechanistic rather than RCT-driven, and effect sizes specific to Raynaud's are not well established.
What the trials show. No high-quality RCT has tested magnesium as a primary intervention for Raynaud's attack frequency. The supporting evidence is indirect: magnesium status is associated with vascular reactivity, and correcting deficiency can improve endothelial function in cardiovascular studies. Some smaller series report symptomatic improvement, but these are not blinded.
Dose used in trials. 200 to 400 mg/day of elemental magnesium, split into morning and evening doses with food.
Form to look for. Glycinate, citrate, or malate. Oxide is poorly absorbed and tends to cause loose stools at the doses needed.
Skip if you have stage 3b or worse chronic kidney disease (eGFR < 45) or are on potassium-sparing diuretics without monitoring. Otherwise, the safety margin is wide.
Actionable takeaway: if your Raynaud's is primary and not on anticoagulation, EGb 761 ginkgo at 120 mg twice or three times daily, layered with 1 g/day combined EPA/DHA and 200–400 mg/day magnesium, is the most defensible starting stack. Reassess attack frequency at 8 to 10 weeks.
Supplements With Moderate Evidence (Consider With Caveats)
L-arginine
The mechanistic story is clean: L-arginine is the substrate for endothelial nitric oxide synthase and supports vasodilation. The trial picture in Raynaud's is mixed. A 2002 placebo-controlled study showed no benefit at 8 g/day for 28 days in primary Raynaud's, while smaller open-label and IV-administration protocols in scleroderma-associated Raynaud's have shown some acute digital perfusion improvement. If you're going to try it, the typical oral dose is 3–6 g/day in divided doses. Skip if you've had cold sores or shingles recently (arginine can shift the arginine-to-lysine ratio that favors herpes reactivation), if you've had a recent myocardial infarction (post-MI mortality signal in one trial), or if you're on PDE5 inhibitors or nitrates.
Niacin and inositol hexanicotinate
Niacin and its inositol hexanicotinate form produce vasodilation and historically have been used for Raynaud's symptoms. The "flushing" form (immediate-release niacin) causes uncomfortable cutaneous flushing at therapeutic doses; the inositol hexanicotinate ("no-flush niacin") is gentler but with less robust evidence. A few small trials and a 2006 review suggested modest improvement in cold-induced vasospasm at 500–2,000 mg/day, but these are small, older trials. Skip if you have liver disease, gout, or are already on a statin without monitoring liver enzymes; sustained-release niacin has been linked to hepatotoxicity.
Evening primrose oil (gamma-linolenic acid)
The hypothesis is that GLA shifts prostaglandin balance toward more vasodilatory PGE1. A few older trials in scleroderma-associated Raynaud's (DiGiacomo et al., 1989, n=21) and primary Raynaud's at 3–6 g/day for 8–12 weeks showed modest symptomatic improvement, but study quality is mixed and the effect size is small. Worth considering if you have secondary Raynaud's and want a low-risk adjunct, but I'd put it below ginkgo and omega-3.
N-acetylcysteine
NAC has been tested mostly in scleroderma-associated Raynaud's, often by IV infusion. A 2009 study (Rosato et al., n=50) found IV NAC infusions improved digital blood flow and reduced attack frequency in systemic sclerosis. Oral evidence is weaker. Reasonable to consider if you're under rheumatology care for scleroderma; not a first-pick for primary Raynaud's.
Popular But Evidence-Thin
Vitamin E
Vitamin E is widely recommended in older naturopathic and patient-forum guidance for Raynaud's, framed as a circulation supplement. The actual evidence is thin: older small trials at 400–800 IU/day showed minimal symptomatic benefit, and meta-analyses of high-dose vitamin E in cardiovascular populations have raised concerns about all-cause mortality at doses above 400 IU/day. If you want to try it, the smallest reasonable trial is 200 IU/day of mixed tocopherols for 8 weeks. Mandatory caveat: high-dose vitamin E (>400 IU/day) plus warfarin has a documented bleeding interaction, per the Drugs.com interaction monograph. Do not stack with anticoagulants without prescriber input.
Cocoa flavanols
Cocoa flavanols genuinely improve endothelial function in short-term trials (the CoCoA-style mechanistic studies show measurable brachial flow-mediated dilation improvements at 500–900 mg/day), but no RCT has directly tested attack-frequency reduction in Raynaud's. If you enjoy dark chocolate or unsweetened cocoa, eat it; expect a modest endothelial benefit, not Raynaud's-specific symptom control.
What To Look For When Buying
- Ginkgo: only standardized EGb 761 or equivalent (24% flavone glycosides, 6% terpene lactones). Avoid bargain "ginkgo leaf" with no standardization.
- Omega-3: EPA + DHA per softgel listed clearly, with third-party verification (IFOS, USP, ConsumerLab). Reject any label that only lists "fish oil 1000 mg" without breaking out EPA and DHA.
- Magnesium: glycinate, citrate, or malate. Skip oxide unless you specifically want a laxative effect.
- Red flags: "Raynaud's relief blend" proprietary formulas without per-ingredient dosing, brands without batch testing, and any product claiming to "cure" or "reverse" Raynaud's.
- Dosing strategy: split ginkgo doses (morning and evening), take omega-3 with the largest meal of the day, and take magnesium in the evening if you find it helps sleep.
When Supplements Are Not Enough
See a clinician (rheumatologist preferred) if any of these apply:
- Digital ulcers, fingertip pitting scars, or fingers that turn black or develop sores that don't heal in a few days. These are signs of secondary Raynaud's, often scleroderma-associated, and need rheumatology workup with ANA, anti-centromere, anti-Scl-70, and nailfold capillaroscopy.
- Sclerodactyly (tight, shiny skin on the fingers), puffy fingers, or skin tightening on the forearms.
- Color changes that last hours rather than minutes, or attacks that occur without obvious cold or stress trigger.
- New-onset Raynaud's after age 40, especially with positive ANA or other connective tissue disease features.
- Attacks frequent enough to interfere with work, daily function, or sleep despite cold avoidance and lifestyle measures. This is the threshold where a dihydropyridine calcium channel blocker is the standard next step.
If your Raynaud's is interfering with daily life or your fingers are turning black, this is not a supplement-first situation. See a rheumatologist.
FAQ
Does ginkgo work as well as nifedipine for Raynaud's?
No. The one head-to-head RCT (Choi et al., 2008) found nifedipine reduced attack frequency by about 51% vs about 31% for ginkgo. Ginkgo is a reasonable option if you can't tolerate a calcium channel blocker (orthostasis, edema, headache) or want an adjunct, but nifedipine is the stronger intervention.
Is Raynaud's an autoimmune disease?
Primary Raynaud's is not autoimmune. Secondary Raynaud's is often associated with an autoimmune connective tissue disease (scleroderma, lupus, mixed connective tissue disease, Sjögren's). The distinction matters because secondary Raynaud's needs rheumatology workup and management of the underlying disease.
Can magnesium alone fix Raynaud's?
No. Magnesium has a mild vasodilator effect and is useful if you're deficient or borderline, but there are no RCTs showing it works as monotherapy. Think of it as a low-risk supportive layer, not a Raynaud's-specific therapy.
Are omega-3s safe with my anticoagulant?
At 1–2 g/day, the bleeding risk is small but real. The Cleveland Clinic and most cardiology references consider this dose acceptable on therapeutic anticoagulation with monitoring. Doses above 3 g/day and combinations with ginkgo or high-dose vitamin E need explicit prescriber clearance.
What about diet and lifestyle?
Cold avoidance with layered gloves and hand warmers, smoking cessation (nicotine is a potent vasoconstrictor), stress management, and biofeedback have the strongest non-pharmacologic evidence base. Diet contributions to Raynaud's are modest, but a Mediterranean-pattern diet rich in oily fish and leafy greens supports the same endothelial pathways the supplements target. For magnesium-rich food sources, see our breakdown in Best Magnesium for Sleep.
Conclusion: The Bottom Line on Best Supplements for Raynaud's
Standardized ginkgo (EGb 761) is the supplement with the most consistent RCT evidence for primary Raynaud's, with attack-frequency reductions in the 30–55% range across small trials. That's real, but smaller than what you'd expect from a dihydropyridine calcium channel blocker. Omega-3 EPA/DHA and magnesium are defensible secondary layers, especially if you have cardiovascular risk overlap. Vitamin E, L-arginine, and cocoa flavanols are popular but evidence-thin for Raynaud's specifically. The harder question isn't which supplement to add. It's whether your Raynaud's is primary or secondary, because that single distinction reorganizes the entire treatment plan. If you have features pointing to secondary disease, a rheumatology workup comes before the supplement aisle.
Next steps:
- Read our editorial standards page on how we review supplements so you understand the evidence weighting behind these picks.
- If you want a deeper dive into the omega-3 form and dosing question, see Best Omega-3 Supplements.
- Bring this list to your primary care doctor or rheumatologist before adding ginkgo or high-dose vitamin E, especially if you're on warfarin, apixaban, clopidogrel, or daily aspirin.
This article is for informational purposes and not medical advice. Supplements can interact with medications and health conditions. Consult a licensed physician before starting any supplement, particularly if you are pregnant, nursing, taking prescription medications, or managing a chronic condition such as scleroderma, lupus, or any cardiovascular disease.
Reviewed by Michael Ward, MD MPH, Preventive Medicine, focused on guideline-based chronic disease management.
Recommended Products
As an Amazon Associate, UsefulVitamins.com earns from qualifying purchases at no extra cost to you. We only recommend products supported by published research or third-party testing.
